Company / R&D Expense
Globus Medical R&D Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D Expense
$147.2M
FY2025
5-year range
$60.1M / $163.8M
FY2021-FY2025
Trend
-10.1%
vs FY2024
Sector context
#47 of 110
Health Care
What the data says
At $147M, Globus Medical's r&d expense ranks #47 of 110 in the Health Care sector. R&D Expense has fluctuated over the past 10 years, ranging from $31M in FY2016 to $164M in FY2024.
Based on SEC 10-K filings.
$147M in FY2025 with a 5-year CAGR of +21.6%.
Improved from $124M to $147M over the past 2 years.
Health Care sector context is included.
R&D Expense over time
Growth rates
- 3-Year CAGR
- +26.3%
- 5-Year CAGR
- +21.6%
- 10-Year CAGR
- -
Sector benchmark
#47 of 110 in Health CareTop 43% of 110This company $147.2M Sector average $298.2M
▼
-50.6% below sector average
Key checks
Key Insights
- 5-year CAGR of +21.6%, indicating consistent growth.
- In FY2025, r&d expense decreased 10.1% year-over-year.
- Ranks #47 out of 110 companies in the Health Care sector.
- Peak r&d expense was recorded in FY2024.
Company context
Key Data Points
- Altman Z-Score 3.91 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $147.2M | -10.1% |
| FY2024 | $163.8M | +32.0% |
| FY2023 | $124.0M | +69.8% |
| FY2022 | $73.0M | +21.5% |
| FY2021 | $60.1M | +8.2% |
| FY2020 | $55.5M | -7.6% |
| FY2019 | $60.1M | +34.9% |
| FY2018 | $44.5M | +2.0% |
| FY2017 | $43.7M | +40.1% |
| FY2016 | $31.2M | +16.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026